Pricing Log in Create free account

InterCure Ltd. (INCR) vs Talphera, Inc. (TLPH)

InterCure Ltd. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. and Talphera, Inc. are of similar size ($55.5M and $55.1M). Talphera, Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 8.8×. InterCure Ltd. grew revenue faster over the last twelve months: 16.2% against −73.1%. InterCure Ltd. has the higher net margin (4.88% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, InterCure Ltd. leads on 12 and Talphera, Inc. on 3.

Valuation

Metric INCR TLPH Drug Manufacturers Specialty & Generic median
P/E 8.80 n/m 19.25
P/S 0.33 191.48 2.11
P/B 0.33 5.66 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 7.24 n/m 12.58
EV/Sales 0.66 166.32 2.73
Earnings yield 11.36% (25.00%) (4.38%)
Free cash flow yield (2.02%) (11.83%) 0.00%

Profitability

Metric INCR TLPH Drug Manufacturers Specialty & Generic median
Gross margin 32.74% 100.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 4.88% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (143.36%) (0.40%)
Return on assets 0.00% (69.60%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INCR TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 16.15% (73.07%) 10.01%
EPS growth (last fiscal year) 52.50% 32.00% 49.06%
Revenue growth, 5-year CAGR 31.11% (58.55%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INCR TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.27 0.00 0.05
Current ratio 1.85 4.29 2.31
Net debt to EBITDA (4.07) 1.50 0.97

Dividend

Metric INCR TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric INCR TLPH Drug Manufacturers Specialty & Generic median
Market cap 55.10m 55.54m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack